Augmedix Profit Margin

The latest profit margin for AUGX is -46.23% as of June 2024. That compares with -57.72% in the prior-year period — up 19.9% year over year. That is below the sector sector average of 13.09%. Investors often review this figure alongside Augmedix's historical trend and sector peers before judging valuation or financial health.

Over the past year, AUGX's profit margin moved from -57.72% to -46.23% — a 19.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Augmedix's valuation or profitability profile.

Against its sector companies, AUGX currently prints -46.23% for profit margin, while the sector average sits near 13.09%. That is roughly 453.2% below the sector mean. Large gaps often invite a closer look at Augmedix's growth, margins, and balance sheet.

Profit Margin shows how effectively Augmedix converts resources into returns. At -46.23%, AUGX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -57.72% in the prior-year period — up 19.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AUGX's profit margin (-46.23%), review year-over-year change from -57.72%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.